| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| NHINational Health Investors, Inc. | 3.83B | 80.43 | 25.70 | 4.8% | 41.42% | 9.83% | 5.32% | 0.83 |
| DHCDiversified Healthcare Trust | 1.33B | 5.50 | -3.55 | 6.04% | -22.9% | -20.85% | 8.43% | 1.49 |
| AHRAmerican Healthcare REIT, Inc. | 8.94B | 47.98 | -165.45 | 11.38% | 1.24% | 1% | 0.94% | 0.81 |
| NHPBPNational Healthcare Properties, Inc. | 18.48 | 2.27% | -22.97% | -12.27% | 1.67 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 980.29M | 1.05B | 1.13B | 1.22B | 1.18B | 1.26B | 1.62B | 1.86B | 2.07B |
| Revenue Growth % | - | 0.07% | 0.08% | 0.08% | -0.03% | 0.07% | 0.28% | 0.15% | 0.11% |
| Property Operating Expenses | 800.1M | 837.64M | 923.82M | 1B | 1.03B | 1.08B | 1.28B | 1.5B | 1.65B |
| Net Operating Income (NOI) | - | - | - | - | - | - | - | - | - |
| NOI Margin % | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 28.68M | 32.17M | 28.42M | 29.75M | 27.01M | 43.2M | 245.38M | 280.11M | 279.99M |
| G&A Expenses | 28.68M | 32.17M | 28.42M | 29.75M | 27.01M | 43.2M | 103.1M | 104.98M | 100.8M |
| EBITDA | 423.73M | 293.05M | 275.41M | 329.68M | 264M | 292.62M | 291.19M | 314.01M | 358.42M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 272.21M | 113.63M | 96.27M | 140.12M | 132.43M | 153.81M | 200.6M | 237.3M | 221.64M |
| D&A / Revenue % | - | - | - | - | - | - | - | - | - |
| Operating Income | 151.51M | 179.43M | 179.14M | 189.55M | 131.57M | 138.81M | 90.59M | 76.72M | 136.78M |
| Operating Margin % | - | - | - | - | - | - | - | - | - |
| Interest Expense | 45.66M | 60.87M | 66.28M | 78.55M | 71.28M | 80.94M | 105.96M | 163.19M | 127.73M |
| Interest Coverage | 3.32x | 2.95x | 2.70x | 2.41x | 1.85x | 1.72x | 0.85x | 0.47x | 1.07x |
| Non-Operating Income | 271.58M | 113.64M | 96.03M | 111.41M | 98.86M | 133.19M | 57.43M | -10.25M | 42.94M |
| Pretax Income | -203.55M | 2.12M | 13.74M | -860K | 5.79M | -52.31M | -72.8M | -76.22M | -33.89M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 8K | -8K | -3.08M | 956K | 586K | 663K | 1.71M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - |
| Net Income | -146.03M | 11.22M | 13.3M | -4.96M | 2.16M | -47.79M | -81.3M | -71.47M | -37.81M |
| Net Margin % | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | - | 1.08% | 0.18% | -1.37% | 1.44% | -23.1% | -0.7% | 0.12% | 0.47% |
| Funds From Operations (FFO) | - | - | - | - | - | - | - | - | - |
| FFO Margin % | - | - | - | - | - | - | - | - | - |
| FFO Growth % | - | -0.01% | -0.12% | 0.23% | -0% | -0.21% | 0.13% | 0.39% | 0.11% |
| FFO per Share | - | - | - | - | - | - | - | - | - |
| FFO Payout Ratio % | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | -3.01 | 0.23 | 0.27 | -0.11 | 0.03 | -0.72 | -1.23 | -1.08 | -0.29 |
| EPS Growth % | - | 1.08% | 0.17% | -1.41% | 1.3% | -23.02% | -0.71% | 0.12% | 0.73% |
| EPS (Basic) | -3.01 | 0.23 | 0.27 | -0.11 | 0.03 | -0.72 | -1.23 | -1.08 | -0.29 |
| Diluted Shares Outstanding | 48.55M | 49.56M | 49.99M | 45.48M | 66.05M | 66.21M | 66.21M | 66.05M | 130.64M |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 2.79B | 2.8B | 2.89B | 3.17B | 3.23B | 4.58B | 4.79B | 4.58B | 4.49B |
| Asset Growth % | - | 0% | 0.03% | 0.1% | 0.02% | 0.42% | 0.05% | -0.04% | -0.02% |
| Real Estate & Other Assets | 26.66M | 23.2M | 24.51M | 22.79M | 21.68M | 23.06M | 26.36M | 3.53B | 3.47B |
| PP&E (Net) | 2.14B | 2.16B | 2.22B | 2.49B | 2.53B | 3.67B | 3.86B | 227.85M | 163.99M |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Total Current Assets | 269.55M | 275.51M | 303.29M | 331.44M | 356.95M | 330.74M | 341.92M | 297.1M | 354.89M |
| Cash & Equivalents | 29.12M | 33.66M | 35.13M | 53.15M | 113.21M | 81.6M | 65.05M | 43.45M | 76.7M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 83.67M | 87.89M | 100.75M | 77.08M | 55.6M | 66.37M | 72.72M | 48.8M | 47.61M |
| Intangible Assets | 200.83M | 180.31M | 179.52M | 160.25M | 154.69M | 248.87M | 236.28M | 180.47M | 161.47M |
| Total Liabilities | 1.34B | 1.42B | 1.63B | 2.07B | 2.16B | 2.75B | 3.14B | 3.12B | 2.18B |
| Total Debt | 1.19B | 1.25B | 1.45B | 1.85B | 1.88B | 2.5B | 2.83B | 3.02B | 1.87B |
| Net Debt | 1.16B | 1.22B | 1.42B | 1.79B | 1.76B | 2.42B | 2.77B | 2.98B | 1.79B |
| Long-Term Debt | 1.15B | 1.24B | 1.45B | 1.64B | 1.68B | 1.43B | 2.24B | 1.34B | 1.02B |
| Short-Term Borrowings | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K |
| Capital Lease Obligations | 0 | 0 | 0 | 13.06M | 251.22M | 145.49M | 273.07M | 225.5M | 165.24M |
| Total Current Liabilities | 107.33M | 126.56M | 144.79M | 173.72M | 194.68M | 1.11B | 560.57M | 1.47B | 946.86M |
| Accounts Payable | 37.18M | 43.97M | 43.03M | 62.2M | 67.83M | 64.41M | 83.69M | 242.91M | 258.32M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 46.8M | 41.03M | 38.47M | 48.77M | 89.27M | 60.78M | 60.38M | 82.23M | 54.86M |
| Total Equity | 1.45B | 1.38B | 1.26B | 1.1B | 1.07B | 1.83B | 1.65B | 1.46B | 2.3B |
| Equity Growth % | - | -0.05% | -0.09% | -0.12% | -0.03% | 0.7% | -0.1% | -0.12% | 0.58% |
| Shareholders Equity | 1.26B | 1.19B | 1.06B | 900.55M | 866.11M | 1.58B | 1.4B | 1.27B | 2.26B |
| Minority Interest | 187.27M | 191.16M | 196.37M | 202.21M | 208.72M | 248.28M | 249.27M | 188.86M | 42.93M |
| Common Stock | 1.96M | 1.99M | 1.98M | 1.94M | 1.8M | 658K | 661K | 661K | 1.56M |
| Additional Paid-in Capital | 1.75B | 1.79B | 1.77B | 1.73B | 1.73B | 2.53B | 2.54B | 2.55B | 3.72B |
| Retained Earnings | -490.3M | -598.04M | -704.75M | -827.55M | -864.27M | -951.3M | -1.14B | -1.28B | -1.46B |
| Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | -0.05% | 0% | 0% | -0% | 0% | -0.01% | -0.02% | -0.02% | -0.01% |
| Return on Equity (ROE) | -0.1% | 0.01% | 0.01% | -0% | 0% | -0.03% | -0.05% | -0.05% | -0.02% |
| Debt / Assets | 0.43% | 0.45% | 0.5% | 0.58% | 0.58% | 0.55% | 0.59% | 0.66% | 0.42% |
| Debt / Equity | 0.82x | 0.91x | 1.16x | 1.67x | 1.75x | 1.37x | 1.72x | 2.07x | 0.81x |
| Net Debt / EBITDA | 2.74x | 4.16x | 5.15x | 5.44x | 6.68x | 8.27x | 9.51x | 9.48x | 5.01x |
| Book Value per Share | 29.87 | 27.83 | 25.14 | 24.25 | 16.27 | 27.63 | 24.91 | 22.09 | 17.64 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 114.36M | 128.1M | 106.81M | 117.45M | 219.16M | 17.91M | 147.77M | 98.53M | 176.09M |
| Operating CF Growth % | - | 0.12% | -0.17% | 0.1% | 0.87% | -0.92% | 7.25% | -0.33% | 0.79% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - |
| Net Income | -146.03M | 11.22M | 13.3M | -4.96M | 2.16M | -53.27M | -73.38M | -76.89M | -35.6M |
| Depreciation & Amortization | 277.67M | 121.42M | 103.31M | 144.14M | 132.95M | 157.38M | 200.6M | 237.3M | 221.64M |
| Stock-Based Compensation | 1.82M | 1.2M | 3.24M | 2.96M | -1.19M | 9.66M | 3.91M | 5.47M | 9.87M |
| Other Non-Cash Items | -2M | 16.82M | 8.08M | 24.24M | 10.97M | -2.39M | 54.44M | -11.55M | 48.86M |
| Working Capital Changes | -17.09M | -22.57M | -21.12M | -48.92M | 74.19M | -93.47M | -37.8M | -55.79M | -68.68M |
| Cash from Investing | -352.69M | -124.55M | -135.77M | -103.11M | -147.94M | -138.65M | -118.58M | 9.4M | -8.73M |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 | -650K | -18.57M | -12.93M | -235K |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | -306.7M | -81M | -68.86M | -10.28M | -19.64M | -58.31M | -28.49M | 122.11M | 83.44M |
| Cash from Financing | 226.66M | 4.76M | 37.6M | 2.69M | -8.81M | 94.11M | -42.92M | -129.06M | -134.74M |
| Dividends Paid | -51.68M | -55.78M | -59.97M | -62.61M | -27M | -22.79M | -51.12M | -76.28M | -120.89M |
| Common Dividends | -51.68M | -55.78M | -59.97M | -62.61M | -27M | -22.79M | -51.12M | -76.28M | -120.89M |
| Debt Issuance (Net) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | -1000K |
| Share Repurchases | -20.94M | -30.66M | -76.58M | -89.89M | -23.11M | -382K | -20.7M | -469K | -14K |
| Other Financing | 9.77M | 1.71M | -8.42M | -17.98M | -724K | -29.04M | -33.93M | -34.72M | -382.64M |
| Net Change in Cash | -11.81M | 8.47M | 8.56M | 17.18M | 62.31M | -26.7M | -13.58M | -21.12M | 32.52M |
| Exchange Rate Effect | -140K | 149K | -77K | 145K | -90K | -74K | 154K | 7K | -91K |
| Cash at Beginning | 67.49M | 55.68M | 64.14M | 72.7M | 89.88M | 152.19M | 125.49M | 111.91M | 90.78M |
| Cash at End | 55.68M | 64.14M | 72.7M | 89.88M | 152.19M | 125.49M | 111.91M | 90.78M | 123.3M |
| Free Cash Flow | 68.37M | 84.55M | 39.91M | 24.62M | 90.85M | -61.78M | 76.25M | -1.26M | 84.15M |
| FCF Growth % | - | 0.24% | -0.53% | -0.38% | 2.69% | -1.68% | 2.23% | -1.02% | 68% |
| FCF / Revenue % | - | - | - | - | - | - | - | - | - |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 2.6 | 2.52 | 2.19 | 2.97 | 2.04 | 1.6 | 1.8 | 2.51 | 1.41 |
| FFO Payout Ratio | 40.96% | 44.68% | 54.74% | 46.32% | 20.06% | 21.5% | 42.85% | 46% | 65.77% |
| NOI Margin | 18.38% | 20.17% | 18.35% | 17.96% | 13.39% | 14.4% | 20.77% | 19.19% | 20.13% |
| Net Debt / EBITDA | 2.74x | 4.16x | 5.15x | 5.44x | 6.68x | 8.27x | 9.51x | 9.48x | 5.01x |
| Debt / Assets | 42.6% | 44.77% | 50.27% | 58.22% | 58% | 54.62% | 59.19% | 65.95% | 41.68% |
| Interest Coverage | 3.32x | 2.95x | 2.70x | 2.41x | 1.85x | 1.72x | 0.85x | 0.47x | 1.07x |
| Book Value / Share | 29.87 | 27.83 | 25.14 | 24.25 | 16.27 | 27.63 | 24.91 | 22.09 | 17.64 |
| Revenue Growth | - | 7.03% | 7.83% | 7.92% | -2.98% | 6.7% | 27.97% | 14.94% | 11.38% |
| 2024 | |
|---|---|
| Resident Fees and Services | 1.88B |
| Resident Fees and Services Growth | - |
| 2024 | |
|---|---|
| UNITED STATES | 2.06B |
| UNITED STATES Growth | - |
| International | 6.63M |
| International Growth | - |
American Healthcare REIT, Inc. (AHR) reported $2.20B in revenue for fiscal year 2024. This represents a 124% increase from $980.3M in 2016.
American Healthcare REIT, Inc. (AHR) grew revenue by 11.4% over the past year. This is steady growth.
Yes, American Healthcare REIT, Inc. (AHR) is profitable, generating $27.3M in net income for fiscal year 2024 (-1.8% net margin).
Yes, American Healthcare REIT, Inc. (AHR) pays a dividend with a yield of 1.93%. This makes it attractive for income-focused investors.
American Healthcare REIT, Inc. (AHR) has a return on equity (ROE) of -2.0%. Negative ROE indicates the company is unprofitable.
American Healthcare REIT, Inc. (AHR) generated Funds From Operations (FFO) of $235.8M in the trailing twelve months. FFO is the primary profitability metric for REITs.